Delisting Determination,The Nasdaq Stock Market, LLC,
April 29, 2010, La Jolla Pharmaceutical Company. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of La Jolla Pharmaceutical Company
(the Company), effective at the opening of the trading
session on May 10, 2010. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5110(a) and 5100. The Company was
notified of the Staffs determination on January 19, 2010.
The Company requested a review of that determation by the Hearings
Panel. Upon review of the information provided by the Company,
the Panel issed a decision dated March 2, 2010, which notified
the Company that trading in the Companys securities would be
suspended on March 4, 2010. The Company did not request a
review of the Panels decision by the Nasdaq Listing and
Hearing Review Council. The Listing Council did not call the
matter for review. The Panels Determination to delist
the Company became final on April 16, 2010.